BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li L, Yang C, Li S, Liu Y, Li H, Hu S, Zhou H, Wang J, Shen H, Meng X, Li J, Xu T. TMEM88 modulates the secretion of inflammatory factors by regulating YAP signaling pathway in alcoholic liver disease. Inflamm Res 2020;69:789-800. [DOI: 10.1007/s00011-020-01360-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhao X, Li G, Chong T, Xue L, Luo Q, Tang X, Zhai X, Chen J, Zhang X. TMEM88 exhibits an antiproliferative and anti-invasive effect in bladder cancer by downregulating Wnt/β-catenin signaling. J Biochem Mol Toxicol 2021;35:e22835. [PMID: 34057764 DOI: 10.1002/jbt.22835] [Reference Citation Analysis]
2 Zhou H, Zhu X, Yao Y, Su Y, Xie J, Zhu M, He C, Ding J, Xu Y, Shan R, Wang Y, Zhao X, Ding Y, Liu B, Shao Z, Liu Y, Xu T, Xie Y. TMEM88 Modulates Lipid Synthesis and Metabolism Cytokine by Regulating Wnt/β-Catenin Signaling Pathway in Non-Alcoholic Fatty Liver Disease. Front Pharmacol 2021;12:798735. [PMID: 35058782 DOI: 10.3389/fphar.2021.798735] [Reference Citation Analysis]
3 Liu ZN, Wu X, Fang Q, Li ZX, Xia GQ, Cai JN, Lv XW. CD73 Attenuates Alcohol-Induced Liver Injury and Inflammation via Blocking TLR4/MyD88/NF-κB Signaling Pathway. J Inflamm Res 2022;15:53-70. [PMID: 35023943 DOI: 10.2147/JIR.S341680] [Reference Citation Analysis]
4 Cai M, Ni WJ, Wang YH, Wang JJ, Zhou H. Targeting TMEM88 as an Attractive Therapeutic Strategy in Malignant Tumors. Front Oncol 2022;12:906372. [PMID: 35734592 DOI: 10.3389/fonc.2022.906372] [Reference Citation Analysis]